Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Tau histopathological lesion type correlates of structural magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) biomarkers in 4-repeat tauopathies.
Movement Disorders
S36 - Movement Disorders: Clinical and Pathologic Characterization of Neurodegenerative Movement Disorders (1:24 PM-1:36 PM)
003

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) show 4-repeat tau deposition in neurons (neurofibrillary tangles and neuropil threads), oligodendrocytes (coiled bodies) and astrocytes (tufted astrocytes [PSP] or astrocytic plaques [CBD]). Determining how MRI findings relate to underlying pathology is critical to evaluate their utility as surrogate markers to aid in diagnosis and as outcome measures for clinical trials.

To determine the relationship between tau lesion burden and MRI volume loss and DTI white matter tract abnormalities in 4-repeat tauopathies.

Forty-seven patients with antemortem 3T MRI including volumetric and DTI scans and postmortem pathological diagnosis of PSP (n=28) or CBD (n=19) were included. Tau lesion types were semiquantitatively graded in disease-specific regions. Regional volumes, fractional anisotropy (FA), and mean diffusivity (MD) were correlated using linear regression models with tau lesion scores considered separately, based on cellular type (neuronal vs glial), or summed (total tau).

Greater total tau burden correlated with volume loss in the globus pallidus (p=0.004), subthalamic nucleus (p<0.001), substantia nigra (p=0.024), red nucleus (p=0.003) and midbrain (p<0.001), with glial lesions (mostly coiled bodies) driving the associations. Neuronal lesions trended to associate with volume of the precentral cortex (p=0.061). Decreased FA and increased MD in the superior cerebellar peduncle (SCP) correlated with glial tau in cerebellar dentate (p=0.037 and p=0.019, respectively) and red nucleus (p<0.001 for both). In the midbrain, glial pathology correlated with increased MD (p=0.008). Finally, increased subcortical white matter MD was related to total tau in superior frontal (p=0.020) and precentral (p=0.017) cortices.

MRI volume of key subcortical and brainstem regions, SCP degeneration and subcortical white matter abnormalities correlated with tau deposition at autopsy making them good surrogate markers of pathology. Moreover, volume correlated with glial lesions in subcortical and brainstem areas but trended to associate with neuronal lesions in cortical regions, possibly suggesting different pathomechanisms.

Authors/Disclosures

PRESENTER
No disclosure on file
Nirubol Tosakulwong No disclosure on file
Stephen Weigand No disclosure on file
Marina Buciuc, MD (MUSC) Dr. Buciuc has nothing to disclose.
Farwa Ali, MD (Mayo Clinic) Dr. Ali has nothing to disclose.
Heather Clark No disclosure on file
Hugo Botha, MD (Mayo School of Graduate Medical Education, Rochester) Dr. Botha has received research support from NIH.
Joseph Duffy No disclosure on file
Rene Utianski No disclosure on file
Mary M. Machulda, PhD (Mayo Clinic) The institution of Dr. Machulda has received research support from NIH.
Christopher Schwarz No disclosure on file
Robert I. Reid No disclosure on file
Matthew Senjem (Mayo Clinic) Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Clifford R. Jack, Jr., MD (Mayo Clinic) The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
J. E. Ahlskog, MD, PhD (Mayo Clinic) Dr. Ahlskog has received publishing royalties from a publication relating to health care.
Dennis W. Dickson, MD (Mayo Clinic) Dr. Dickson has nothing to disclose.
Keith A. Josephs, Jr., MD, FAAN (Mayo Clinic) Dr. Josephs has nothing to disclose.
Jennifer Whitwell, PhD (Mayo Clinic) Dr. Whitwell has nothing to disclose.